Chartwell Investment Partners’s Axonics, Inc. Common Stock AXNX Stock Holding History

Chartwell Investment Partners’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-21,377	Closed	-$1.17M	–	436
2023 Q1	$1.17M	Sell	21,377 -12,323	-37%	-$720K	0.04%	328
2022 Q4	$2.11M	Sell	33,700 -17,774	-35%	-$1.18M	0.08%	261
2022 Q3	$3.63M	Buy	51,474 +1,802	+4%	+$124K	0.15%	209
2022 Q2	$2.81M	Buy	49,672 +1,242	+3%	+$68.1K	0.11%	245
2022 Q1	$3.03M	Buy	48,430 +2,027	+4%	+$109K	0.1%	255
2021 Q4	$2.6M	Sell	46,403 -827	-2%	-$50.5K	0.08%	278
2021 Q3	$3.07M	Sell	47,230 -14,247	-23%	-$972K	0.1%	249
2021 Q2	$3.9M	Buy	61,477 +27,660	+82%	+$1.63M	0.11%	234
2021 Q1	$2.02M	Buy	+33,817	New	+$1.84M	0.06%	283

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Chartwell Investment Partners's AXNX Position: Q2 2023 in Review

Chartwell Investment Partners sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2023, closing a stake of 21,377 shares — an estimated $1.17M sold.

Chartwell Investment Partners first reported a position in AXNX in Q1 2021 and held it in 9 quarters. The position peaked at $3.9M in Q2 2021. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2023.

Chartwell Investment Partners reported no remaining Axonics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Chartwell Investment Partners sold 21,377 Axonics, Inc. Common Stock shares in Q2 2023, an estimated $1.17M.
Chartwell Investment Partners first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 9 quarters.
Chartwell Investment Partners's Axonics, Inc. Common Stock position peaked at $3.9M in Q2 2021.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2023.

Based on Chartwell Investment Partners's 13F filing for Q2 2023, filed 25 Jul 2023.